Abstract
Most people know that there are two main categories of drugs: (1) drugs that can be bought only if prescribed by a licensed practitioner, and (2) drugs that can be purchased “over the counter,” without a prescription. Yet most people know very little about the process for determining whether a drug will be prescription or OTC or about the procedures for switching a drug from Rx-to-OTC status. Public attention has been focused on the switch procedures within the last 2 years primarily because of controversies surrounding the OTC availability of metaproterenol as a bronchodilator and of ibuprofen as an analgesic. A discussion of the statutory scheme and the FDA's established procedures may help to remove some of the confusion that seems to surround the essentially uncomplicated switch process.
Get full access to this article
View all access options for this article.
